Novartis has announced their wholesale price for the newly-approved oral MS drug, Gilenya (aka Fingolimod).
$4,000/month or about $48,000/year
Copaxone: $39,928/year
Rebif: $36,825/year
Betaseron: $34,980/year
Avonex: $34,667/year
$4,000/month or about $48,000/year
Copaxone: $39,928/year
Rebif: $36,825/year
Betaseron: $34,980/year
Avonex: $34,667/year
Comment